Cenmox
Cenmox $ 51,00
Back to products
Cephalexin
Cephalexin Price range: $ 39,00 through $ 349,00

Cephadex

Price range: $ 16,00 through $ 48,00

Cephadex is a highly effective first-generation cephalosporin antibiotic designed to combat a wide range of bacterial infections. It works by inhibiting the growth of bacteria, preventing them from forming the cell walls necessary for their survival. This medication is commonly used to treat respiratory tract infections, skin and soft tissue conditions, and ear infections. It is also an established treatment for urinary tract infections and certain bone-related bacterial issues. With its proven track record, Cephadex provides a reliable solution for restoring health and clearing systemic bacterial pathogens.

Active substance: cephalexin
SKU: Cephadex Category:
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM

Each dosage option has its own packaging choices.

Description

Cephadex belongs to the first-generation cephalosporin class of beta-lactam antibacterial agents. It is prescribed for the treatment of susceptible bacterial infections involving the respiratory tract, skin and skin structures, bone, and urinary system. The medication acts by inhibiting bacterial cell wall synthesis, leading to the destruction of pathogenic microorganisms.

In the United States, Cephadex (cephalexin) is classified as a prescription medication (Rx only) requiring evaluation and authorization by a licensed healthcare provider. Proper clinical assessment and identification of the causative organism are necessary prior to initiating therapy to ensure therapeutic efficacy and limit the development of antimicrobial resistance.

Parameter Details
Active ingredient Cephalexin (as monohydrate)
Therapeutic class First-generation cephalosporin antibiotic
Dosage form Oral capsule, oral tablet, oral suspension
Route of administration Oral
Prescription status Prescription (Rx)
Primary purpose Treatment of susceptible bacterial infections

Main uses

Cephadex is indicated for the management of mild to moderate bacterial infections caused by susceptible strains of designated microorganisms. FDA-approved indications include respiratory tract infections such as streptococcal pharyngitis and tonsillitis, acute otitis media, skin and skin structure infections (including cellulitis and impetigo), and uncomplicated urinary tract infections such as cystitis. Additionally, it may be utilized in bone infections, including osteomyelitis caused by susceptible Gram-positive pathogens such as Staphylococcus aureus or Streptococcus pneumoniae. Cephadex is ineffective against viral pathogens, including those responsible for the common cold, influenza, or viral bronchitis. Any off-label applications must be explicitly determined and monitored by a qualified healthcare professional.

How the drug works

The therapeutic action of Cephadex relies on its bactericidal activity as a beta-lactam antibiotic. It binds specifically to essential penicillin-binding proteins (PBPs) located inside the bacterial cell wall. These target proteins are critical transpeptidase enzymes involved in the final cross-linking stage of peptidoglycan synthesis, which provides structural integrity to the cell wall. By inhibiting PBP activity, Cephadex disrupts cell wall construction during active bacterial multiplication. The resulting osmotic instability leads to cell lysis and bacterial cell death. Cephadex primarily targets Gram-positive aerobic bacteria, including staphylococci and streptococci, as well as select Gram-negative organisms like Escherichia coli, Proteus mirabilis, and Klebsiella pneumoniae.

How it’s absorbed and eliminated

Cephadex exhibits rapid and complete absorption from the upper gastrointestinal tract following oral administration. Peak plasma concentrations are typically achieved within 1 hour after administration under fasting conditions. The presence of food in the stomach may slightly delay peak absorption times, but it does not significantly decrease the overall bio-availability of the active substance. Cephadex distributes broadly into body tissues and fluids, including bone, synovial fluid, and pleural fluid, though penetration into the central nervous system and cerebrospinal fluid remains minimal regardless of meningeal inflammation. Cephadex does not undergo significant hepatic metabolism and is excreted via glomerular filtration and tubular secretion in the urine. Approximately 80% or more of an administered dose is eliminated unchanged in the urine within 8 hours. The serum elimination half-life ranges from 0.5 to 1 hour in individuals with normal renal function, but this period is extended in patients with severe renal impairment.

Dosing schedule

The dosage regimen for Cephadex is individualized based on the specific indication, infection severity, patient age, body weight, and underlying renal function. For adults and pediatric patients over 15 years of age, the standard daily oral dosage ranges from 1 to 4 grams, administered in evenly divided doses every 6 or 12 hours depending on the clinical condition. For mild, uncomplicated urinary tract, skin, or pharyngeal infections, a dose of 250 mg every 6 hours or 500 mg every 12 hours is frequently prescribed. Pediatric patients typically receive a calculated dosage based on body weight, usually 25 to 50 mg per kilogram of body weight per day divided into smaller doses. Capsules and tablets should be swallowed whole with adequate fluid. When administering liquid oral suspensions, a calibrated measuring device must be used to ensure dosing accuracy. Completing the full prescribed course of therapy is required to prevent therapeutic relapse.

Adverse reactions

Treatment with Cephadex is generally well tolerated, though adverse reactions of varying severity may occur. The most frequently reported side effects affect the gastrointestinal tract, including nausea, vomiting, diarrhea, abdominal pain, and dyspepsia. Mild hypersensitivity reactions, such as skin rash, urticaria, and pruritus, are also observed in some individuals. Less common adverse effects include transient elevations in hepatic enzymes, headache, dizziness, fatigue, and genital candidiasis due to altered bacterial flora. A rare but severe complication associated with systemic antibacterial therapy is Clostridioides difficile-associated diarrhea (CDAD), which presents as persistent, watery diarrhea and severe abdominal cramping. Signs of systemic hypersensitivity, including angioedema or toxic epidermal necrolysis, require immediate cessation of the drug and emergency medical evaluation.

Compatibility with other medicines

Concomitant administration of Cephadex with other pharmacological agents can alter drug clearance or enhance toxic risks. Co-administration of probenecid inhibits the renal tubular secretion of Cephadex, resulting in increased plasma concentrations and a prolonged elimination half-life. Concomitant use of oral anticoagulants, such as warfarin, may potentiate prothrombin time elevation, increasing the risk of bleeding; close monitoring of coagulation parameters (such as INR) is advised. Cephadex may also diminish the therapeutic efficacy of live attenuated bacterial vaccines, including the oral typhoid vaccine, by inhibiting bacterial growth. Laboratory test interactions can occur: Cephadex may produce false-positive results in urine glucose tests utilizing copper reduction reagents (such as Benedict’s or Fehling’s solution) and may cause a positive direct Coombs’ test result.

Food and alcohol interactions

Cephadex can be administered with or without food. Taking the dose alongside meals or a light snack can help minimize potential gastrointestinal discomfort, such as mild stomach irritation or nausea. While ethanol does not demonstrate a direct pharmacokinetic interaction with Cephadex, consuming alcohol during an active bacterial infection can impair immune system response, promote dehydration, and aggravate central nervous system or gastrointestinal side effects such as dizziness and stomach upset. Avoiding or limiting alcohol consumption during antibacterial treatment is advisable to facilitate recovery.

If you skip a dose

Maintaining consistent serum levels of the antibiotic is essential for effective bacterial clearance. If a dose of Cephadex is missed, it should be taken as soon as remembered. However, if the time is close to the next scheduled administration, the missed dose should be skipped, and the standard dosing schedule resumed. Patients must not double the dose to make up for a missed administration, as elevated serum concentrations increase the likelihood of adverse effects.

Storage and expiration

Solid oral dosage forms (tablets and capsules) of Cephadex should be stored at controlled room temperature between 20°C and 25°C (68°F to 77°F), with short excursions permitted between 15°C and 30°C (59°F to 86°F). The container should be kept tightly closed to protect the contents from excessive moisture and light. Reconstituted liquid oral suspensions generally require storage under refrigeration between 2°C and 8°C (36°F to 46°F) and must be discarded after 14 days. All pharmaceutical products must be kept safely out of the reach of children.

Special populations

The administration of Cephadex in specialized clinical groups requires careful evaluation. In pregnant patients, Cephadex is used when clearly needed; animal reproductive studies have not shown evidence of fetal toxicity, though adequate and well-controlled human studies remain limited. Cephadex is excreted in low concentrations into human milk, so caution should be exercised when prescribing to nursing mothers. In pediatric populations, dosage calculations must strictly follow weight-based guidelines. In elderly patients or individuals with impaired renal function, dosage adjustment is required based on creatinine clearance rates to prevent excessive drug accumulation.

Important precautions

Prior to initiating Cephadex therapy, careful assessment regarding previous hypersensitivity reactions to cephalosporins, penicillins, or other beta-lactam drugs is mandatory. Cross-hypersensitivity between penicillins and first-generation cephalosporins can occur; severe allergic reactions such as anaphylaxis require immediate emergency management. Prolonged use of antibacterial agents may lead to the overgrowth of non-susceptible organisms, including fungi. Patients with a history of gastrointestinal disease, particularly colitis, must be monitored closely. If severe or persistent diarrhea develops during or following treatment, clinical evaluation for *Clostridioides difficile* colitis is required.

Common questions

Does Cephadex treat viral infections like influenza or the common cold?

No, Cephadex is an antibacterial agent specifically designed to target bacterial organisms. It has no antiviral activity and is ineffective against viral pathogens responsible for influenza, acute viral rhinitis, or bronchitis. Using antibiotics for viral illnesses is clinically inappropriate and contributes to antibiotic resistance.

Can Cephadex be taken by individuals with a known penicillin allergy?

Caution is required. While many patients with mild penicillin allergies tolerate cephalosporins safely, cross-reactivity can occur. Individuals with a history of severe, immediate allergic reactions to penicillin (such as anaphylaxis or angioedema) should generally avoid first-generation cephalosporins like Cephadex unless explicitly directed by an allergist or physician.

What should be done if a dose of Cephadex is forgotten?

If a dose is missed, it should be taken as soon as it is remembered. If it is almost time for the next scheduled dose, skip the missed dose and return to your regular schedule. Do not take two doses at once to make up for the missed one.

Does food affect the absorption or efficacy of Cephadex?

Food does not significantly alter the overall extent of Cephadex absorption, though it may slightly delay the rate of absorption. Taking the medication with food can be helpful if you experience mild stomach discomfort or nausea.

Are gastrointestinal disruptions common during a course of Cephadex?

Mild gastrointestinal symptoms, including nausea, mild diarrhea, and stomach pain, are among the more common adverse effects of oral cephalosporins. However, if diarrhea becomes severe, watery, or accompanied by abdominal cramps and fever, contact a healthcare provider immediately to rule out serious complications.

In accordance with FDA requirements.

Information on this page is for reference and does not replace an assessment by a licensed healthcare professional.

Additional information
Dosage

250 mg

,

500 mg

Package

30 caps

,

60 caps

,

90 caps

,

120 caps

Ενεργός Ουσία